Penumbra : New Thrombectomy Product Launches Support PEN Stock Amid Macro Issues
Penumbra expects to materially increase both revenues and profitability in the company's international business in the next few years.
Read full article »
Penumbra develops clinical products for treating stroke and other neurovascular diseases.
Read more